Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
1.
Clin Microbiol Infect ; 27(7): 1036.e1-1036.e8, 2021 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-33813118

RESUMO

OBJECTIVES: Genotyping of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been instrumental in monitoring viral evolution and transmission during the pandemic. The quality of the sequence data obtained from these genotyping efforts depends on several factors, including the quantity/integrity of the input material, the technology, and laboratory-specific implementation. The current lack of guidelines for SARS-CoV-2 genotyping leads to inclusion of error-containing genome sequences in genomic epidemiology studies. We aimed to establish clear and broadly applicable recommendations for reliable virus genotyping. METHODS: We established and used a sequencing data analysis workflow that reliably identifies and removes technical artefacts; such artefacts can result in miscalls when using alternative pipelines to process clinical samples and synthetic viral genomes with an amplicon-based genotyping approach. We evaluated the impact of experimental factors, including viral load and sequencing depth, on correct sequence determination. RESULTS: We found that at least 1000 viral genomes are necessary to confidently detect variants in the SARS-CoV-2 genome at frequencies of ≥10%. The broad applicability of our recommendations was validated in over 200 clinical samples from six independent laboratories. The genotypes we determined for clinical isolates with sufficient quality cluster by sampling location and period. Our analysis also supports the rise in frequencies of 20A.EU1 and 20A.EU2, two recently reported European strains whose dissemination was facilitated by travel during the summer of 2020. CONCLUSIONS: We present much-needed recommendations for the reliable determination of SARS-CoV-2 genome sequences and demonstrate their broad applicability in a large cohort of clinical samples.


Assuntos
COVID-19/diagnóstico , Técnicas de Genotipagem/normas , Sequenciamento de Nucleotídeos em Larga Escala/normas , SARS-CoV-2/genética , Sequenciamento Completo do Genoma/normas , Artefatos , COVID-19/virologia , Genoma Viral , Técnicas de Genotipagem/métodos , Guias como Assunto , Sequenciamento de Nucleotídeos em Larga Escala/métodos , Humanos , RNA Viral , Reprodutibilidade dos Testes , SARS-CoV-2/isolamento & purificação , Sensibilidade e Especificidade , Sequenciamento Completo do Genoma/métodos , Fluxo de Trabalho
2.
Euro Surveill ; 24(39)2019 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-31576801

RESUMO

BackgroundEnding the HIV pandemic must involve new tools to rapidly identify and control local outbreaks and prevent the emergence of recombinant strains with epidemiological advantages.AimThis observational study aimed to investigate in France a cluster of HIV-1 cases related to a new circulating recombinant form (CRF). The confirmation this CRF's novelty as well as measures to control its spread are presented.MethodsPhylogenetic analyses of HIV sequences routinely generated for drug resistance genotyping before 2018 in French laboratories were employed to detect the transmission chain. The CRF involved was characterised by almost full-length viral sequencing for six cases. Cases' clinical data were reviewed. Where possible, epidemiological information was collected with a questionnaire.ResultsThe transmission cluster comprised 49 cases, mostly diagnosed in 2016-2017 (n = 37). All were infected with a new CRF, CRF94_cpx. The molecular proximity of this CRF to X4 strains and the high median viraemia, exceeding 5.0 log10 copies/mL, at diagnosis, even in chronic infection, raise concerns of enhanced virulence. Overall, 41 cases were diagnosed in the Ile-de-France region and 45 were men who have sex with men. Among 24 cases with available information, 20 reported finding partners through a geosocial networking app. Prevention activities in the area and population affected were undertaken.ConclusionWe advocate the systematic use of routinely generated HIV molecular data by a dedicated reactive network, to improve and accelerate targeted prevention interventions. Geosocial networking apps can play a role in the spread of outbreaks, but could also deliver local targeted preventive alerts.


Assuntos
Infecções por HIV/transmissão , HIV-1/classificação , HIV-1/genética , Filogenia , Recombinação Genética , Adulto , Análise por Conglomerados , DNA Viral/genética , Surtos de Doenças/prevenção & controle , Farmacorresistência Viral/genética , França/epidemiologia , Infecções por HIV/epidemiologia , Infecções por HIV/prevenção & controle , Infecções por HIV/virologia , HIV-1/patogenicidade , Humanos , Masculino , Redes Sociais Online , Filogeografia , Reação em Cadeia da Polimerase Via Transcriptase Reversa , Alinhamento de Sequência , Minorias Sexuais e de Gênero/estatística & dados numéricos , Carga Viral , Viremia/virologia , Virulência , Sequenciamento Completo do Genoma
3.
Curr HIV Res ; 17(3): 190-197, 2019.
Artigo em Inglês | MEDLINE | ID: mdl-31490758

RESUMO

BACKGROUND: HIV infection is a chronic disease for which therapeutic adherence and tolerance require particular attention. OBJECTIVE: This study aimed to assess whether and when therapeutic drug monitoring (TDM) could be associated with a benefit in routine practice. METHODS: All HIV-infected patients who underwent at least one TDM at the University Hospital of Dijon (France) between 1st January 2009 and 31st December 2012 were retrospectively included. Compliance with the recommendations, the results (antiretroviral concentrations), any subsequent therapeutic modifications, and the virological results at 4-8 months were analysed each time TDM was performed. TDM was defined as "practically relevant" when low or high antiretroviral concentrations led to a change in therapy. RESULTS: Of the 571 patients who followed-up, 43.4% underwent TDM. TDM complying with recommendations (120 patients) was associated with a higher proportion of antiretroviral concentrations outside the therapeutic range (p=0.03). Antiretroviral treatment was modified after TDM in 22.6% of patients. Protease inhibitors, non-nucleoside reverse transcriptase inhibitors and raltegravir were more significantly modified when the measured concentration was outside the therapeutic range (p=0.008, p=0.05 and p=0.02, respectively). Overall, 11.7% of TDM was considered "practically relevant", though there was no significant correlation between subsequent changes in antiretroviral treatment and undetectable final HIV viral load. CONCLUSION: TDM may be a useful tool in the management of HIV infection in specific situations, but the overall benefit seems moderate in routine practice. TDM cannot be systematic and/or a decision tool per se, but should be included in a comprehensive approach in certain clinical situations.


Assuntos
Antirretrovirais/farmacocinética , Antirretrovirais/uso terapêutico , Monitoramento de Medicamentos , Infecções por HIV/tratamento farmacológico , Infecções por HIV/epidemiologia , Padrões de Prática Médica , Adulto , Fármacos Anti-HIV/farmacologia , Fármacos Anti-HIV/uso terapêutico , Terapia Antirretroviral de Alta Atividade , Contagem de Linfócito CD4 , Coinfecção/epidemiologia , Monitoramento de Medicamentos/métodos , Feminino , Infecções por HIV/imunologia , Infecções por HIV/virologia , Humanos , Masculino , Pessoa de Meia-Idade , Cooperação do Paciente , Resultado do Tratamento , Carga Viral
4.
Pediatr Res ; 84(1): 118-124, 2018 07.
Artigo em Inglês | MEDLINE | ID: mdl-29795200

RESUMO

BACKGROUND: Prodromal symptoms are frequently reported in the atypical form of Hemolytic uremic syndrome (aHUS) suggesting implication of infectious triggers. Some pathogens may also play a role in the mechanisms of production of autoantibody directed against Factor H (FH), a complement regulator, leading to aHUS. METHODS: The presence of 15 gastrointestinal (GI) pathogens was investigated by using xTAG-based multiplex PCR techniques on stools collected at the acute phase in a cohort of Indian HUS children classified according to the presence or absence of anti-FH autoantibodies. RESULTS: Prevalence of pathogens in patients with anti-FH antibody (62.5%) was twice that in those without (31.5%). Different pathogens were detected, the most frequent being Clostridium difficile, Giardia intestinalis, Salmonella, Shigella, Rotavirus, Norovirus and Entamoeba histolytica. No stool was positive for Shigatoxin. CONCLUSION: This study reveals a higher prevalence of GI pathogens in anti-FH positive than in negative patients. No single pathogen was implicated exclusively in one form of HUS. These pathogens may play a role in the disease initiation by inducing complement activation or an autoimmune response.


Assuntos
Síndrome Hemolítico-Urêmica Atípica/imunologia , Autoanticorpos/imunologia , Ativação do Complemento , Síndrome Hemolítico-Urêmica Atípica/microbiologia , Síndrome Hemolítico-Urêmica Atípica/parasitologia , Síndrome Hemolítico-Urêmica Atípica/virologia , Criança , Pré-Escolar , Clostridioides difficile , Estudos de Coortes , Fator H do Complemento/imunologia , Entamoeba histolytica , Feminino , Giardia lamblia , Humanos , Índia , Lactente , Intestinos/microbiologia , Intestinos/parasitologia , Intestinos/patologia , Intestinos/virologia , Masculino , Reação em Cadeia da Polimerase Multiplex , Mutação , Norovirus , Rotavirus , Salmonella , Shigella
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...